Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
Express Scripts
McKesson
AstraZeneca
Medtronic

Last Updated: September 30, 2022

KLOXXADO Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


When do Kloxxado patents expire, and what generic alternatives are available?

Kloxxado is a drug marketed by Hikma and is included in one NDA. There are three patents protecting this drug.

This drug has thirteen patent family members in seven countries.

The generic ingredient in KLOXXADO is naloxone hydrochloride. There are twelve drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the naloxone hydrochloride profile page.

US Patents and Regulatory Information for KLOXXADO

KLOXXADO is protected by three US patents.

Patents protecting KLOXXADO

Liquid naloxone spray
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: USE OF NALOXONE FOR THE EMERGENCY TREATMENT OF KNOWN OR SUSPECTED OPIOID OVERDOSE, AS MANIFESTED BY RESPIRATORY AND/OR CENTRAL NERVOUS SYSTEM DEPRESSION, FOR ADULT AND PEDIATRIC PATIENTS

Liquid naloxone spray
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: USE OF NALOXONE FOR THE EMERGENCY TREATMENT OF KNOWN OR SUSPECTED OPIOID OVERDOSE, AS MANIFESTED BY RESPIRATORY AND/OR CENTRAL NERVOUS SYSTEM DEPRESSION, FOR ADULT AND PEDIATRIC PATIENTS

Liquid naloxone spray
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma KLOXXADO naloxone hydrochloride SPRAY;NASAL 212045-001 Apr 29, 2021 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Hikma KLOXXADO naloxone hydrochloride SPRAY;NASAL 212045-001 Apr 29, 2021 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Hikma KLOXXADO naloxone hydrochloride SPRAY;NASAL 212045-001 Apr 29, 2021 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for KLOXXADO

See the table below for patents covering KLOXXADO around the world.

Country Patent Number Title Estimated Expiration
Japan 2019528278 液体ナロキソンスプレー See Plans and Pricing
World Intellectual Property Organization (WIPO) 2016007245 See Plans and Pricing
European Patent Office 3500261 PULVÉRISATION DE NALOXONE LIQUIDE (LIQUID NALOXONE SPRAY) See Plans and Pricing
Australia 2017312811 Liquid naloxone spray See Plans and Pricing
Japan 2017519803 舌下ナロキソンスプレー See Plans and Pricing
China 109922805 液体纳洛酮喷雾 (LIQUID NALOXONE SPRAY) See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for KLOXXADO

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1685839 92292 Luxembourg See Plans and Pricing PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Johnson and Johnson
McKesson
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.